🔗 Permalink

Inventor profile of:

Waldemar Priebe

City:

Houston, Texas

Country:

United States

Published Applications:

Last publication date:

2025-01-09

Top Assignees for applications by Waldemar Priebe

The entities that hold a legal rights for patent applications filed by inventor Priebe Waldemar:

Board of Regents, The University of Texas System 24 Austin, TX United States
Moleculin Biotech, Inc. 5 Houston, TX United States
The Board of Regents of the University of Texas System 3 Austin, TX United States
Moleculin LLC 3 Houston, TX United States
INTERTECH BIO 1 Houston, TX United States
Board of Regents, University of Texas Systems The 1 Austin, TX United States
BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM 1 AUSTIN, TX United States
Board of Regents of the University of Texas System 1 Austin, TX United States
Houston Pharmaceuticals, Inc. 1 Houston, TX United States
Board of Regents,The University of Texas System 1 Austin, TX United States
The University of Mississippi Medical Center 1 Jackson, MS United States

Recent patent applications by Priebe Waldemar

Waldemar Priebe from Houston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-01-09

US20250009727A1

Human necessities

WATER-SOLUBLE SALTS OF DNA BINDING AGENTS

#2 | 2024-02-08

US20240041909A1

Human necessities

Preparation of preliposomal annamycin lyophilizate

#3 | 2024-01-25

US20240024345A1

Human necessities

Method of reconstituting liposomal annamycin

#4 | 2023-04-27

US20230130134A1

Human necessities

METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE MONOSACCHARIDES AND ANALOGS THEREOF

#5 | 2022-11-03

US20220347168A1

Human necessities

LUNG TARGETED ANTICANCER THERAPIES WITH LIPOSOMAL ANNAMYCIN

#6 | 2022-06-09

US20220175744A1

Human necessities

COMBINATIONS OF TRANSCRIPTION INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF DISEASE

#7 | 2022-04-07

US20220105116A1

Human necessities

Method of reconstituting liposomal annamycin

#8 | 2022-04-07

US20220105115A1

Human necessities

Preparation of preliposomal Annamycin lyophilizate

#9 | 2022-01-27

US20220023326A1

Human necessities

Esters of 2-deoxy-monosaccharides with anti proliferative activity

#10 | 2019-07-25

US20190224225A1

Human necessities

Esters of 2-deoxy-monosaccharides with anti proliferative activity

#11 | 2019-06-13

US20190177276A1

Chemistry; metallurgy

Caffeic acid derivatives and uses thereof

#12 | 2018-09-06

US20180251454A1

Chemistry; metallurgy

DNA binding agents with a minor groove binding tail

#13 | 2016-06-30

US20160184336A1

Human necessities

Esters of 2-deoxy-monosacharides with anti proliferative activity

#14 | 2015-04-02

US20150094343A1

Chemistry; metallurgy

ORALLY BIOAVAILABLE CAFFEIC ACID RELATED ANTICANCER DRUGS

#15 | 2014-11-06

US20140329901A1

Chemistry; metallurgy

Compounds for treatment of cell proliferative diseases

#16 | 2014-08-14

US20140228414A1

Chemistry; metallurgy

Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

#17 | 2013-09-19

US20130244986A1

Human necessities

METHODS OF TREATING SKIN DISORDERS WITH CAFFEIC ACID ANALOGS

#18 | 2013-05-23

US20130129675A1

Human necessities

INTERFERON THERAPIES IN COMBINATION WITH BLOCKADE OF STAT3 ACTIVATION

#19 | 2012-11-01

US20120276108A1

Chemistry; metallurgy

MONOSACCHARIDE-BASED COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE AND INFLAMMATORY DERMATOLOGICAL DISEASES

#20 | 2012-08-23

US20120214850A1

Chemistry; metallurgy

Compounds for treatment of cell proliferative diseases

#21 | 2012-06-14

US20120149738A1

Chemistry; metallurgy

Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)

#22 | 2011-11-10

US20110275577A1

Human necessities

METHODS OF TREATING DERMATOLOGIC, GYNECOLOGIC, AND GENITAL DISORDERS WITH CAFFEIC ACID ANALOGS

#23 | 2011-06-30

US20110160151A1

Human necessities

Acetates of 2-deoxy monosaccharides with anticancer activity

#24 | 2011-03-03

US20110053992A1

Chemistry; metallurgy

Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

#25 | 2011-01-27

US20110021805A1

Chemistry; metallurgy

Compounds for treatment of cell proliferative diseases

#26 | 2011-01-06

US20110003758A1

Human necessities

Inhibitors of glycolysis useful in the treatment of brain tumors

#27 | 2010-06-17

US20100152143A1

Human necessities

Methods of treating skin disorders with caffeic acid analogs

#28 | 2010-06-17

US20100152121A1

Chemistry; metallurgy

Iodo-hexose compounds useful to treat cancer

#29 | 2010-06-10

US20100144802A1

Human necessities

Small Molecule Inhibitors for Immune Modulation

#30 | 2010-05-27

US20100130434A1

Human necessities

Hexose Compounds to Treat Cancer

#31 | 2010-01-28

US20100022466A1

Human necessities

Thermally-targeted delivery of medicaments including doxorubicin

#32 | 2008-07-10

US20080167277A1

Human necessities

METHODS OF TREATING SKIN DISORDERS WITH CAFFEIC ACID ANALOGS

#33 | 2008-07-10

US20080167220A1

Human necessities

Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

#34 | 2007-10-04

US20070232668A1

Chemistry; metallurgy

Orally bioavailable caffeic acid related anticancer drugs

#35 | 2007-07-03

US9122427

Submicron liposome suspensions obtained from preliposome lyophilizates

#36 | 2007-02-15

US20070037758A1

Chemistry; metallurgy

Anthracycline antibiotics and methods of treating cancer using the same

#37 | 2005-12-15

US20050277680A1

Chemistry; metallurgy

Compounds for treatment of cell proliferative diseases

#38 | 2005-09-15

US20050203177A1

Human necessities

Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

InventorID:

260693 ⎘